PORTFOLIO NEWS ALEDADE HONORED AS ONE OF GLASSDOOR’S BEST PLACES TO WORK IN 2020 Dec 11, 2019 BlackThorn Therapeutics Reports Data Supporting Phase 2 Development of KOR Antagonist, BTRX-335140, in Depression and Other CNS Disorders Dec 11, 2019 Twist Bioscience and Pandion Therapeutics Expand Antibody Optimization Collaboration Dec 11, 2019 Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2019 Financial Results Dec 11, 2019 Editas Medicine Announces In Vivo Proof-Of-Concept Data For EDIT-301, In Development For The Treatment Of Sickle Cell Disease And Beta-Thalassemia Dec 9, 2019 Syneos Health and AiCure Announce partnership to Optimize Patient Engagement and Trial Success Nov 12, 2019 Editas Medicine and Celgene Corp Amend Existing Collaboration Nov 12, 2019 Twist Biopharma Implements Genedata Biologics to Advance Synthetic Biology-driven Antibody Discovery Nov 8, 2019 AiCure Raises $24.5 Million Series C Round to Broaden its Strategic Value for Life Sciences Nov 7, 2019 eGenesis Announces $100M Series B Financing Nov 7, 2019 « Older Entries Next Entries » PORTFOLIO PRESS COVERAGE FierceBiotech: With $110M and Johns Hopkins tech, Thrive aims to make early cancer screening routine May 30, 2019 To Catch Early Cancer, and Rivals, Thrive Banks on Hopkins Blood Test May 30, 2019 Healthcare Finance: The Top 25 Voices in Precision Medicine announced by BIS Research May 22, 2019 Medium: Google Cares About your Heart: Verve Therapeutics Explodes out of Stealth Mode May 15, 2019 Forbes | Gene Hackers: The Young Biotech Entrepreneurs Looking To Make Billions By Editing Life Itself May 15, 2019 International Business Times: Google Jumps Into Gene Editing: 5 Things You Need To Know May 13, 2019 UMass Boston News | UMass Boston’s Venture Development Center Hits $1 Billion Funding Milestone May 7, 2019 PRSync: Biomatics Capital Invests in Leading Gene Therapy Delivery Platform Apr 26, 2019 Using animal organs in humans: ‘It’s just a question of when’ Apr 3, 2019 MIT Technology Review | Genome engineers made more than 13,000 CRISPR edits in a single cell Mar 26, 2019 « Older Entries Next Entries »
BlackThorn Therapeutics Reports Data Supporting Phase 2 Development of KOR Antagonist, BTRX-335140, in Depression and Other CNS Disorders Dec 11, 2019
Editas Medicine Announces In Vivo Proof-Of-Concept Data For EDIT-301, In Development For The Treatment Of Sickle Cell Disease And Beta-Thalassemia Dec 9, 2019
Syneos Health and AiCure Announce partnership to Optimize Patient Engagement and Trial Success Nov 12, 2019
Twist Biopharma Implements Genedata Biologics to Advance Synthetic Biology-driven Antibody Discovery Nov 8, 2019
AiCure Raises $24.5 Million Series C Round to Broaden its Strategic Value for Life Sciences Nov 7, 2019
FierceBiotech: With $110M and Johns Hopkins tech, Thrive aims to make early cancer screening routine May 30, 2019
Forbes | Gene Hackers: The Young Biotech Entrepreneurs Looking To Make Billions By Editing Life Itself May 15, 2019
UMass Boston News | UMass Boston’s Venture Development Center Hits $1 Billion Funding Milestone May 7, 2019
MIT Technology Review | Genome engineers made more than 13,000 CRISPR edits in a single cell Mar 26, 2019
